Evidence map›Paper›PMID 42034810›Full record

ArticleScientific reports2026

Design and optimization of double semi-cylindrical plasmonic nanostructures for enhanced light harvesting in ultrathin CIGS solar cells.

Hamid Bahador, Abolfazl Jangjoy, Azadeh Nilghaz

Abstract read
In one paragraph

Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Hamid BahadorDepartment of Electrical and Computer Engineering, University of Mohaghegh Ardabili, Ardabil, Iran. hamid.bahador@uma.ac.ir.
Abolfazl JangjoyDepartment of Electrical and Computer Engineering, University of Mohaghegh Ardabili, Ardabil, Iran.
Azadeh NilghazDrug Delivery, Disposition, and Dynamics, Monash University, Parkville, VIC, 3052, Australia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This work presents a theoretical study on ultrathin Cu(InxGa1-x)Se2 (CIGS) solar cells with an absorber thickness of only 200 nm, enhanced by plasmonic nanoparticles (NPs). The inherent trade-off reduced absorber thickness, and sufficient light absorption was addressed by investigating metallic nanoparticles of silver (Ag), gold (Au), aluminum (Al), nickel (Ni), and titanium (Ti) in spherical and cylindrical configurations. Building on this approach, a single semi-cylindrical geometry was introduced to minimize optical losses, and the inter-particle spacing was systematically optimized to maximize light trapping. Three-dimensional finite difference time domain (3D-FDTD) simulations revealed that the interaction between coupled NPs strengthens both the localized fields around the NPs and the scattered fields within the absorber, leading to more efficient carrier generation. In the optimized case, the semi-cylindrical double NPs (DNP) structure exhibited a 29% higher near-field intensity at the resonance wavelength of 731 nm compared with the single half-cylindrical design, highlighting the crucial role of plasmonic coupling. As a result, the short-circuit current density (JSC) increased from 22.50 (mA/cm²) to 31.12 mA/cm², representing an increase of 38.3%. In addition, the power conversion efficiency (PCE) increased by 40.3%, from 12.97% to 18.20%. These findings demonstrate that carefully engineered plasmonic nanostructures can substantially enhance the performance of next-generation thin-film CIGS photovoltaic devices.

Indexed as

CIGS solar cellEfficiency enhancementLight trappingUltrathin absorber

Identifiers

PMID42034810
PMCPMC13284342

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.